Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes.

Aharony S, Baniel J, Yossepowitch O.

BJU Int. 2011 Oct;108(8 Pt 2):E179-83. doi: 10.1111/j.1464-410X.2011.10210.x. Epub 2011 May 26.

PMID:
21615850
[PubMed - indexed for MEDLINE]
2.

Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.

Schwalb MD, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR.

J Urol. 1994 Aug;152(2 Pt 1):382-7.

PMID:
8015076
[PubMed - indexed for MEDLINE]
3.

[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].

Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.

Arch Esp Urol. 2002 Jan-Feb;55(1):41-9. Spanish.

PMID:
11957750
[PubMed - indexed for MEDLINE]
4.

Value of selective upper tract cytology for recognition of upper tract tumors after treatment of superficial bladder cancer.

Gögüs C, Baltaci S, Sahinli S, Türkölmez K, Bedük Y, Göğüs O.

Int J Urol. 2003 May;10(5):243-6.

PMID:
12694462
[PubMed - indexed for MEDLINE]
5.

Natural history of positive urinary cytology after radical cystectomy.

Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G.

J Urol. 2006 Nov;176(5):2000-5; discussion 2005.

PMID:
17070236
[PubMed - indexed for MEDLINE]
6.

[Patients with clinically unconfirmed positive urinary cytology --retrospective analysis of clinical courses].

Kurimura Y, Takahashi A, Hirobe M, Kunishima Y, Masumori N, Matsukawa M, Ito N, Tsukamoto T.

Hinyokika Kiyo. 2007 Jul;53(7):455-8. Japanese.

PMID:
17702177
[PubMed - indexed for MEDLINE]
Free Article
7.

The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.

Sadek S, Soloway MS, Hook S, Civantos F.

J Urol. 1999 Jan;161(1):77-9; discussion 79-80.

PMID:
10037373
[PubMed - indexed for MEDLINE]
9.

Urine cytology in bladder tumors.

Zein TA, Milad MF.

Int Surg. 1991 Jan-Mar;76(1):52-4. Review.

PMID:
2045253
[PubMed - indexed for MEDLINE]
10.

Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

Thalmann GN, Markwalder R, Walter B, Studer UE.

J Urol. 2002 Oct;168(4 Pt 1):1381-5.

PMID:
12352398
[PubMed - indexed for MEDLINE]
11.

Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma.

Murta CB, Antunes AA, Dall'Oglio MF, Mosconi A, Leite KR, Srougi M.

Clinics (Sao Paulo). 2008 Apr;63(2):223-8.

PMID:
18438577
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.

Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF.

Cancer. 1994 Mar 15;73(6):1708-15.

PMID:
8156499
[PubMed - indexed for MEDLINE]
13.

Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.

Degtyar P, Neulander E, Zirkin H, Yusim I, Douvdevani A, Mermershtain W, Kaneti J, Manor E.

Urology. 2004 Feb;63(2):398-401.

PMID:
14972510
[PubMed - indexed for MEDLINE]
14.

Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.

Bergman J, Reznichek RC, Rajfer J.

BJU Int. 2008 Jan;101(1):26-9. Epub 2007 Sep 10.

PMID:
17850364
[PubMed - indexed for MEDLINE]
15.

A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.

Poulakis V, Witzsch U, De Vries R, Altmannsberger HM, Manyak MJ, Becht E.

BJU Int. 2001 Nov;88(7):692-701.

PMID:
11890239
[PubMed - indexed for MEDLINE]
16.

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.

Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I.

Cancer. 2007 Dec 25;111(6):517-24.

PMID:
17963263
[PubMed - indexed for MEDLINE]
Free Article
17.

Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.

Okegawa T, Odagane A, Ide H, Horie S, Nutahara K, Higashihara E.

Int J Urol. 2006 May;13(5):493-7.

PMID:
16771714
[PubMed - indexed for MEDLINE]
18.

Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.

Ray ER, Chatterton K, Khan MS, Thomas K, Chandra A, O'Brien TS.

BJU Int. 2009 May;103(10):1363-7. doi: 10.1111/j.1464-410X.2008.08238.x. Epub 2008 Dec 8.

PMID:
19076151
[PubMed - indexed for MEDLINE]
19.

The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.

Giella JG, Ring K, Olsson CA, Karp FS, Benson MC.

J Urol. 1992 Aug;148(2 Pt 1):293-6.

PMID:
1635121
[PubMed - indexed for MEDLINE]
20.

[Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].

Cariou G, Maaraoui N, Cortesse A.

Prog Urol. 1997 Feb;7(1):51-5. French.

PMID:
9116739
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk